This article is more than 5 years old. Information may no longer be current.

VIDEO: Sustained DME treatment stabilizes central subfield thickness

ByChristopher D Riemann, MD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

VANCOUVER, British Columbia — Christopher D. Riemann, MD, of Cincinnati Eye Institute, discusses his research regarding central subfield thickness in diabetic macular edema patients receiving Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg, Alimera Sciences). Continuous treatment has shown a stabilization over time of OCT central subfield thickness, he said.